Table 2 |
||||
| In vivo anti-tumor effects of DHA and DHA N/O/W emulsion on growth of H22tumor in ICR mice (n = 10) | ||||
| Group | Dose (mg/kg) | Body weight (g) (initial/endpoint) | Tumor weight (g) | TIR (%) |
| NS control | - | 21.9 ± 1.3/27.8 ± 2.2 | 1.4 ± 0.4 | - |
| DHA solution | 11.25 | 21.2 ± 1.2/25.3 ± 1.7 | 1.1 ± 0.3 | 21.5* |
| DHA N/O/W (low dose) | 11.25 | 22.3 ± 0.9/28.6 ± 2.3 | 1.1 ± 0.2 | 23.0* |
| DHA N/O/W (high dose) | 45.00 | 21.7 ± 1.1/26.3 ± 3.8 | 0.7 ± 0.2 | 51.8** |
Note: *P < 0.05 and **P < 0.01 vs. N.S. control.
#P < 0.05 vs. DHA solution or low-dose group.
Wang et al. Nanoscale Research Letters 2012 7:219 doi:10.1186/1556-276X-7-219